Skip to main content
SpringerLink
Log in

Lateral and Mediastinal Lymph Node Dissection in Differentiated Thyroid Carcinoma: Indications, Benefits, and Risks

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

There are 3 compartments of regional lymph nodes to which thyroid carcinoma metastasizes: central, lateral, and mediastinal compartments. The central compartment is the nearest to the thyroid and usually dissected routinely. However, the indication for dissection of the lateral and mediastinal compartments for differentiated thyroid carcinoma remains an open question.

Methods

The indication for dissection of lateral and mediastinal compartments is evaluated based on previous reports, including those from our department.

Results

There is nothing controversial about the indication for therapeutic lateral node dissection for tumors with clinically apparent lateral node metastasis. Such cases are more likely to show recurrence, especially in previously dissected compartments, and surgeons must perform dissection carefully. Although there are no randomized studies on the indication for prophylactic lateral node dissection, it is recommended for papillary carcinoma with aggressive characteristics such as large size and massive extrathyroid extension. Prophylactic mediastinal dissection via median sternotomy is not recommended.

Conclusions

Node dissection of the lateral and mediastinal compartments must be performed aggressively and radically to prevent recurrence in previously dissected regions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Noguchi S, Noguchi A, Murakami N. Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer 1970;26:1053–1060

    Article  PubMed  CAS  Google Scholar 

  2. Shaha AR, Byers RM, Terz JJ. Thyroid cancer surgical practice guidelines. In: Practice Guidelines for Major Cancer Sites. Arlington Heights, IL: Society of Surgical Oncology, 1997; pp 19–97

  3. Roher HD, Simon D, Goretzki PE. Guidelines in oncologic surgery: malignant thyroid tumors. Langenbecks Arch Surg 1997;114(Suppl II):142

    CAS  Google Scholar 

  4. Ito Y, Jikuzono T, Higashiyiama T, et al. Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg 2006;30:1821–1828

    Article  PubMed  Google Scholar 

  5. Dralle H, Gimm O. Lymphadenektomie beim schilddrusencarcinom. Chirurg 1996;67:788–806

    Article  PubMed  CAS  Google Scholar 

  6. Martenson H, Terins J. Recurrent laryngeal nerve palsy in thyroid gland surgery related to operations and nerves at risk. Arch Surg 1985;120:475–482

    Google Scholar 

  7. Scheumann GF, Seeliger H, Musholt TF, et al. Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 1996;162:677–684

    PubMed  CAS  Google Scholar 

  8. Sobin LH, Wittekind C (editors). UICC; TNM classification of malignant tumors, 6th ed. New York: Wiley-Liss, 2002

    Google Scholar 

  9. Noguchi S, Murakami N, Yamashita H, et al. Papillary thyroid carcinoma. Modified radical neck dissection improves prognosis. Arch Surg 1998;133:276–280

    Article  PubMed  CAS  Google Scholar 

  10. Kupferman ME, Patterson DM, Mandel SJ, et al. Safety of modified radical neck dissection for differentiated thyroid carcinoma. Laryngoscope 2004;114:403–406

    Article  PubMed  Google Scholar 

  11. Simon D, Goretzki PE, Witte J, et al. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 1996;20:860–866

    Article  PubMed  CAS  Google Scholar 

  12. Cady B, Sedwick CE, Meissner WA, et al. Risk factor analysis in differentiated thyroid carcinoma. Cancer 1979;43:810–820

    Article  PubMed  Google Scholar 

  13. Buckwalter JA, Thomas CG. Selection of surgical treatment for well-differentiated thyroid carcinomas. Ann Surg 1972;176:565–578

    PubMed  CAS  Google Scholar 

  14. Ito J, Noguchi S, Murakami N, et al. Factors affecting the prognosis of patients with carcinoma of the thyroid. Surg Gynecol Obstet 1980;150:539–544

    PubMed  CAS  Google Scholar 

  15. Rosen IB, Maitland A. Changing the operative strategy for thyroid cancer by node sampling. Am J Surg 1983;146:504–508

    Article  PubMed  CAS  Google Scholar 

  16. McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 1986;61:978–996

    PubMed  CAS  Google Scholar 

  17. DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinomas. J Clin Endocrinol Metab 1990;71:414–424

    Article  PubMed  CAS  Google Scholar 

  18. Coburn MC, Wanebo HJ. Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Ann Surg 1992;164:671–676

    Article  CAS  Google Scholar 

  19. Orsenigo E, Beretta E, Mari G, et al. Modified neck dissection in the treatment of differentiated thyroid carcinoma. Eur J Surg Oncol 1997;23:286–288

    Article  PubMed  CAS  Google Scholar 

  20. Ducci M, Appetecchia M, Marzetti M. Neck dissection for surgical treatment of lymph node metastasis in papillary thyroid carcinoma. J Exp Clin Cancer Res 1997;16:333–335

    PubMed  CAS  Google Scholar 

  21. Mann B, Buhr HJ. Lymph node dissection in patients with differentiated thyroid carcinoma—who benefits? Langenbecks Arch Surg 1998;383:355–358

    Article  PubMed  CAS  Google Scholar 

  22. Palazzo FF, Gosnell J, Savio TS, et al. Lymphadenectomy for papillary thyroid cancer: Changes in practice over four decades. Eur J Surg Oncol 2006;32:340–344

    Article  PubMed  CAS  Google Scholar 

  23. Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794–804

    Article  PubMed  CAS  Google Scholar 

  24. Scheumann GFW, Gimm O, Wegener G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994;18:559–568

    Article  PubMed  CAS  Google Scholar 

  25. Sellers M, Beenken S, Blankenship A, et al. Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg 1992;164:578–581

    Article  PubMed  CAS  Google Scholar 

  26. Ozaki O, Ito K, Kobayashi K, et al. Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid. World J Surg 1988;12:825–829

    Article  PubMed  CAS  Google Scholar 

  27. Heinrich S, Schafer M, Rousson V, et al. Evidence-based treatment of acute pancreatitis. A look at established paradigms. Ann Surg 2006;243:154–168

    Article  PubMed  Google Scholar 

  28. Noguchi M, Kumaki T, Kaniya T, et al. Bilateral cervical lymph node metastases in well-differentiated thyroid cancer. Arch Surg 1990;125:804–806

    PubMed  CAS  Google Scholar 

  29. Sato N, Oyamatsu M, Koyama Y, et al. Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol 1998;69:151–155

    Article  PubMed  CAS  Google Scholar 

  30. Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma. A study of the EORTIC thyroid cancer cooperative group. Eur J Cancer 1979;15:1033–1041

    PubMed  CAS  Google Scholar 

  31. Cady B, Rossi R. An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery 1988;104:947–953

    PubMed  CAS  Google Scholar 

  32. Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088–1095

    PubMed  CAS  Google Scholar 

  33. Hay ID, Berqstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic system in a cohort of 1779 patients surgically treated at one institution during 1970 through 1989. Surgery 1993;114:1050–1057

    PubMed  CAS  Google Scholar 

  34. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981;70:511–518

    Article  PubMed  CAS  Google Scholar 

  35. Cunningham MP, Duda RB, Recant W, et al. Survival discriminants for differentiated thyroid cancer. Am J Surg 1990;160:344–347

    Article  PubMed  CAS  Google Scholar 

  36. Bacourt F, Asselain B, Savoie JC, et al. Multivariate study of prognostic factors in differentiated thyroid carcinoma and re-evaluation of the important of age. Br J Surg 1986;73:274–277

    Article  PubMed  CAS  Google Scholar 

  37. Attie JN. Modified neck dissection in treatment of thyroid cancer: a safe procedure. Eur J Cancer Clin Oncol 1988;24:315–324

    Article  PubMed  CAS  Google Scholar 

  38. Grabe SKG, Hay ID. Thyroid cancer nodal metastasis. Surg Oncol Clin N Am 1996;5:43–63

    Google Scholar 

  39. Wanebo HJ, Andrews W, Kaiser DL. Thyroid cancer: some basic considerations. Am J Surg 1981;142:474–479

    Article  PubMed  CAS  Google Scholar 

  40. Cady B. Surgery of thyroid cancer. World J Surg 1981;5:3–14

    Article  PubMed  CAS  Google Scholar 

  41. Franssila KO. Prognosis in thyroid carcinoma. Cancer 1975;36:1138–1146

    Article  PubMed  CAS  Google Scholar 

  42. Lungdren CI, Hall P, Dickman PW, et al. Clinically significant prognostic factors for differentiated thyroid carcinoma. A population-based, nested case–control study. Cancer 2006;106:524–531

    Article  Google Scholar 

  43. Marchesi M, Biffoni M, Biancan F, et al. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma. Eur J Surg 2002; 558(Suppl):46–50

    Google Scholar 

  44. Machens A, Hinze R, Thomusch O, et al. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002;26:22–28

    Article  PubMed  Google Scholar 

  45. Yokozawa T, Miyauchi A, Kuma K, et al. Accurate and simple method of diagnosing thyroid nodules by the modified technique of ultrasound-guided fine needle aspiration biopsy. Thyroid 1995;5:141–145

    Article  PubMed  CAS  Google Scholar 

  46. Ito Y, Tomoda C, Uruno T, et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 2005;30:91–99

    Article  Google Scholar 

  47. Ito Y, Tomoda C, Uruno T, et al. Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 2004;28:1115–1121

    Article  PubMed  Google Scholar 

  48. Machens A, Holzhausen HJ, Dralle H. Skip metastasis in thyroid cancer leaping the central lymph node compartment. Arch Surg 2004;139:43–45

    Article  PubMed  Google Scholar 

  49. Antonelli A, et al. Role of neck ultrasonography in follow-up of patients operated on for different thyroid cancer. Thyroid 1995;5:25–29

    Article  PubMed  CAS  Google Scholar 

  50. Uruno T, Miyauchi A, Shimizu K, et al. Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg 2005;29:493–495

    Google Scholar 

  51. Ito Y, Uruno R, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003;13:381–388

    Article  PubMed  Google Scholar 

  52. Ito Y, Miyauchi A. Therapeutic strategies for papillary microcarcinoma of the thyroid. Curr Cancer Ther Rev 2005;1:19–25

    Article  Google Scholar 

  53. Ito Y, Tomoda C, Uruno T, et al. Preoperative ultrasonographic examination for lymph node metastasis is useful when designing lymph node dissection for papillary microcarcinoma. World J Surg 2004;28:498–501

    Article  PubMed  Google Scholar 

  54. Ito Y, Uruno T, Takamura Y, et al. Papillary microcarcinoma of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination. Oncology 2005;68:87–96

    Article  PubMed  CAS  Google Scholar 

  55. Ito Y, Tomoda C, Uruno T, et al. Ultrasound-detectable and anatomopathologically-detectable node metastasis in the lateral compartment as indicators of worse relapse-free survival in patients with papillary carcinoma. World J Surg 2005;29:917–920

    Article  PubMed  Google Scholar 

  56. Ito Y, Tomoda C, Uruno T, et al. Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 2006;30:780–786

    Article  PubMed  Google Scholar 

  57. Ito Y, Miyauchi A. An investigation for appropriate surgical treatment of papillary thyroid carcinoma (in Japanese). Endocrine Surg (in press)

  58. Ohshima A, Yamashita H, Noguchi S, et al. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Arch Surg 2000;135:1194–1198

    Article  PubMed  CAS  Google Scholar 

  59. Uruno T, Miyauchi A, Shimizu K, et al. Prognosis after reoperation for local recurrence of papillary thyroid carcinoma. Surg Today 2004;34:891–895

    Article  PubMed  Google Scholar 

  60. Harwood J, Clark OH, Dunphy JE. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg 1978;136:107–112

    Article  PubMed  CAS  Google Scholar 

  61. Sisson GA, Edison BD, Bytell DE. Transsternal radical neck dissection. Arch Otolaryngol 1973;101:46–49

    Google Scholar 

  62. Block MA, Miller JM, Horn RC Jr. Significance of mediastinal lymph node metastases in carcinoma of the thyroid. Am J Surg 1972;123:702–705

    Article  PubMed  CAS  Google Scholar 

  63. Sugenoya A, Asanuma K, Shingu K, et al. Clinical evaluation of upper mediastinal dissection for differentiated thyroid carcinoma. Surgery 1993;113:541–544

    PubMed  CAS  Google Scholar 

  64. Mueller-Gaetner H-W, Brzac HT, Rehpenning W. Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma. Cancer 1991;67:1903–1911

    Article  Google Scholar 

  65. Brennan MD, Bergstaralh EJ, van Heerden JA, et al. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970; initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1991;66:11–22

    PubMed  CAS  Google Scholar 

  66. Shaha AR, Loree TR, Shah JP. Prognostic factors and risk groups analysis in follicular carcinoma of the thyroid. Surgery 1995;118:1131–1138

    Article  PubMed  CAS  Google Scholar 

  67. Chow S-M, Law SC, Mendenhall WM, et al. Follicular thyroid carcinoma; prognostic factors and the role of radioiodine. Cancer 2002;95:488–498

    Article  PubMed  Google Scholar 

  68. Passler C, Scheuba C, Prager G, et al. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer 2004;11:131–139

    Article  PubMed  CAS  Google Scholar 

  69. Basic N, Zgajnar J, Hocevar M, et al. Is patient’s age a prognostic factor for follicular thyroid carcinoma in the TNM classification system? Thyroid 2005;15:439–448

    Article  Google Scholar 

  70. Besic N, Auersperg M, Golouh R. Prognostic factors in follicular carcinoma of the thyroid—a multivariate survival analysis. Eur J Surg Oncol 1999;25:599–605

    Article  PubMed  CAS  Google Scholar 

  71. Witte J, Goretzki PE, Dieken J, et al. Importance of lymph node metastasis in follicular thyroid cancer. World J Surg 2002;26:1017–1022

    Article  PubMed  Google Scholar 

  72. Ito Y, Yoshida H, Nakano K, et al. Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid. Br J Cancer 2002;86:912–916

    Article  PubMed  CAS  Google Scholar 

  73. Ito Y, Miyoshi E, Yoshida H, et al. 14-3-3 sigma possibly plays a constitutive role in papillary carcinoma, but not in follicular tumor of the thyroid. Cancer Lett 2003;200:161–166

    Article  PubMed  CAS  Google Scholar 

  74. Ito Y, Yoshida H, Tomoda C, et al. Caveolin-1 and 14-3-3 sigma expression in follicular variant of thyroid papillary carcinoma. Pathol Res Pract 2005;201:545–549

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Kuma Hospital, 8-2-35, Shimoyamate-dori, Chuo-ku, 650-0011, Kobe, Japan

    Yasuhiro Ito & Akira Miyauchi

Authors
  1. Yasuhiro Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akira Miyauchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasuhiro Ito.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ito, Y., Miyauchi, A. Lateral and Mediastinal Lymph Node Dissection in Differentiated Thyroid Carcinoma: Indications, Benefits, and Risks. World J Surg 31, 905–915 (2007). https://doi.org/10.1007/s00268-006-0722-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-006-0722-0

Keywords

Search

Navigation